Results
1 -
10 of
52Dosa Peter I., Amin Elizabeth Ambrose.
Tactical Approaches to Interconverting GPCR Agonists and Antagonists, Journal of Medicinal Chemistry, 2015 Roles of group II metabotropic glutamate receptors in modulation of seizure activity, Naunyn-Schmiedeberg's Archives of Pharmacology Dopaminergic Hyperactivity in Striatum in Schizophrenia: A Failure of Cortical Glutamatergic Control?, Catecholamine Research In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders, Psychopharmacology Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats, Psychopharmacology Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion, Psychopharmacology Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans, Psychopharmacology Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and d-amphetamine models of schizophrenia, Psychopharmacology Keep an Open Mind, Pharmaceutical & Diagnostic Innovation